Solid-Phase Synthesis as a Tool to Create Exactly Defined, Branched Polymer Vectors for Cell Membrane Targeting

Johanna K. Elter,Veronika Liščáková,Oliver Moravec,Martina Vragović,Marcela Filipová,Petr Štěpánek,Pavel Šácha,Martin Hrubý,Veronika Liščáková,Martina Vragović,Marcela Filipová,Petr Štěpánek,Pavel Šácha,Martin Hrubý
DOI: https://doi.org/10.1021/acs.macromol.3c02600
IF: 5.5
2024-01-26
Macromolecules
Abstract:Modern drug formulations often require, besides the active drug molecule, auxiliaries to enhance their pharmacological properties. Tailor-made, biocompatible polymers covalently connected to the drug molecule can fulfill this function by increasing its solubility, reducing its toxicity, and guiding it to a specific target. If targeting membrane-bound proteins, localization of the drug close to the cell membrane and its target is beneficial to increase drug efficiency and residence time. In this study, we present the synthesis of highly defined, branched polymeric structures with membrane-binding properties. One to three hydrophilic poly(ethylene oxide) or poly(2-ethyloxazoline) side chains were connected via a peptoid backbone using a two-step iterative protocol for solid-phase peptoid synthesis. Additional groups, e.g., a hydrophobic anchor for membrane attachment, were introduced. Due to the nature of solid-phase synthesis, the number and order of the side chains and additional units can be precisely defined. The method proved to be versatile for the generation of multifunctional, branched polymeric structures of molecular weights up to approximately 7000 g mol<sup>-1</sup>. The behavior of all compounds towards biological membranes and cells was investigated using liposomes as cell membrane models, HEK293 and U251-MG cell lines, and red blood cells, thereby demonstrating their potential value as drug auxiliaries with cell membrane affinity.
polymer science
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper aims to solve the problem of how to improve the localization efficiency and residence time of drug molecules on the cell membrane in the drug delivery system. Specifically, the research objective is to enhance the interaction between drug molecules and the cell membrane by synthesizing polymer carriers with specific structures, thereby improving the efficacy and targeting of drugs. #### Background problems 1. **Low water solubility and rapid clearance**: Small - molecule drugs usually have problems of poor water solubility and being easily and rapidly cleared, which significantly reduces the effectiveness of the drugs. 2. **Biocompatibility and side effects**: Some drugs may have problems of insufficient biocompatibility or produce adverse side effects. 3. **Cell membrane targeting**: In order to improve the targeting of drugs to specific cell membrane proteins, it is necessary to design drug carriers that can bind closely to the cell membrane. #### Solutions To solve the above problems, the researchers developed a method based on solid - phase synthesis (Solid - Phase Synthesis, SPS) to create precisely defined polymer carriers with branched structures. These carriers have the following characteristics: - **High - precision control**: Through solid - phase synthesis, the number and sequence of side chains can be precisely controlled to ensure the consistent structure of each molecule. - **Multifunctionality**: Hydrophilic polyethylene glycol (PEG) or poly(2 - ethyl oxazoline) (PEtOx) side chains and hydrophobic anchoring groups (such as stearic acid) are introduced to achieve multivalent binding of drug molecules and cell membrane localization. - **Cell membrane affinity**: By introducing hydrophobic anchoring groups, the polymer - drug conjugates can be brought close to the cell membrane, increasing the local drug concentration and prolonging the residence time of the drug at the site of action. #### Experimental verification To verify the performance of these polymer carriers, the researchers used multiple model systems for testing, including: - **Liposomes**: As an artificial cell membrane model, to evaluate the binding ability of polymer carriers to the cell membrane. - **Cell lines**: Such as HEK293 and U251 - MG cell lines, used to evaluate cytotoxicity and the impact on metabolic activity. - **Red blood cells**: To evaluate hemolysis and ensure the safety of the carriers. Through these experiments, the researchers demonstrated the potential of these new polymer carriers in improving drug cell membrane targeting and residence time, providing new ideas and technical means for future drug delivery systems.